Completed PHASE1 INTERVENTIONAL NCT00003956

Combination Chemotherapy in Treating Patients With Advanced Cancer

A Phase I Study of Continuous Oral Administration of SCH 66336 and 5-Fluorouracil/Leucovorin (5FU/LV) in Patients With Advanced Cancer

Sponsor: Memorial Sloan Kettering Cancer Center

Conditions Lymphoma Unspecified Adult Solid Tumor, Protocol Specific

Interventions fluorouracil leucovorin calcium lonafarnib

Updated 5 times since 2017 Last updated: Apr 2, 2013 Started: Apr 30, 1999 Primary completion: Jan 31, 2001 Completion: Dec 31, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00003956, this PHASE1 trial focuses on Lymphoma and Unspecified Adult Solid Tumor, Protocol Specific and remains completed. Sponsored by Memorial Sloan Kettering Cancer Center, it has been updated 5 times since 1999, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1
Jan 2017 — Jun 2018 [monthly]

Completed PHASE1

First recorded

Apr 1999

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)

Data source: National Cancer Institute (NCI)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• New York, United States